Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Current Deferred Revenue: 2013-2014

Historic Current Deferred Revenue for Tvardi Therapeutics (TVRD) over the last 2 years, with Dec 2014 value amounting to $1.5 million.

  • Tvardi Therapeutics' Current Deferred Revenue fell 97.10% to $89,000 in Q2 2015 from the same period last year, while for Jun 2015 it was $89,000, marking a year-over-year decrease of 97.10%. This contributed to the annual value of $1.5 million for FY2014, which is 58.22% down from last year.
  • According to the latest figures from FY2014, Tvardi Therapeutics' Current Deferred Revenue is $1.5 million, which was down 58.22% from $3.5 million recorded in FY2013.
  • Tvardi Therapeutics' 5-year Current Deferred Revenue high stood at $3.5 million for FY2013, and its period low was $1.5 million during FY2014.
  • Moreover, its 2-year median value for Current Deferred Revenue was $2.5 million (2013), whereas its average is $2.5 million.
  • Data for Tvardi Therapeutics' Current Deferred Revenue shows a maximum YoY tumbled of 58.22% (in 2014) over the last 5 years.
  • Yearly analysis of 2 years shows Tvardi Therapeutics' Current Deferred Revenue stood at $3.5 million in 2013, then crashed by 58.22% to $1.5 million in 2014.